Correlation Between Orchestra BioMed and Burzynski Research
Can any of the company-specific risk be diversified away by investing in both Orchestra BioMed and Burzynski Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orchestra BioMed and Burzynski Research into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orchestra BioMed Holdings and Burzynski Research, you can compare the effects of market volatilities on Orchestra BioMed and Burzynski Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orchestra BioMed with a short position of Burzynski Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orchestra BioMed and Burzynski Research.
Diversification Opportunities for Orchestra BioMed and Burzynski Research
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Orchestra and Burzynski is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Orchestra BioMed Holdings and Burzynski Research in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Burzynski Research and Orchestra BioMed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orchestra BioMed Holdings are associated (or correlated) with Burzynski Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Burzynski Research has no effect on the direction of Orchestra BioMed i.e., Orchestra BioMed and Burzynski Research go up and down completely randomly.
Pair Corralation between Orchestra BioMed and Burzynski Research
Given the investment horizon of 90 days Orchestra BioMed is expected to generate 5.84 times less return on investment than Burzynski Research. But when comparing it to its historical volatility, Orchestra BioMed Holdings is 1.81 times less risky than Burzynski Research. It trades about 0.02 of its potential returns per unit of risk. Burzynski Research is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 2.10 in Burzynski Research on September 3, 2024 and sell it today you would earn a total of 1.40 from holding Burzynski Research or generate 66.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Orchestra BioMed Holdings vs. Burzynski Research
Performance |
| Timeline |
| Orchestra BioMed Holdings |
| Burzynski Research |
Orchestra BioMed and Burzynski Research Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Orchestra BioMed and Burzynski Research
The main advantage of trading using opposite Orchestra BioMed and Burzynski Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orchestra BioMed position performs unexpectedly, Burzynski Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burzynski Research will offset losses from the drop in Burzynski Research's long position.| Orchestra BioMed vs. Tandy Leather Factory | Orchestra BioMed vs. Westinghouse Air Brake | Orchestra BioMed vs. Citi Trends | Orchestra BioMed vs. Nike Inc |
| Burzynski Research vs. ProKidney Corp | Burzynski Research vs. Orchestra BioMed Holdings | Burzynski Research vs. Lixte Biotechnology Holdings | Burzynski Research vs. Oncology Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |